Unknown

Dataset Information

0

CPA4 Promotes EMT in Pancreatic Cancer via Stimulating PI3K-AKT-mTOR Signaling.


ABSTRACT: Background:Carboxypeptidase A4 (CPA4), as a novel tumor biomarker, is prevalently observed in various cancers. However, the potential role of CPA4 in pancreatic cancer (PC), to our knowledge, has not been fully clarified. Materials and Methods:We systematically explored the detailed function of CPA4 in epithelial to mesenchymal transition (EMT) stimulated PC in human clinical samples and in vitro. Results:CPA4 was overexpressed in clinical PC samples that was positively related with tumor size (P=0.026), T stage (P=0.011), lymph-node metastasis (P=0.026) and a worse prognosis for PC patients (P=0.001). Interestingly, CPA4 was inversely correlated with E-cadherin (r=-0.372, P=0.003) in clinical samples and PC cell lines which cooperatively contributed to a worse prognosis (P=0.005) for PC patients. CPA4 overexpression enhanced EMT in AsPC-1 and Capan-2 cells, which promoted EMT-like cellular morphology and cell invasion and migration. Meanwhile, CPA4 overexpression activated EMT and PI3K-AKT-mTOR signaling, following with the downregulation of E-cadherin and ?-catenin, and the upregulation of N-cadherin, vimentin, p-PI3K (Tyr458), p-AKT (Ser473) and p-mTOR (Ser2448). However, PI3K inhibitor LY294002 reversed CPA4 overexpression-stimulated EMT in vitro. Moreover, CPA4 was co-immunoprecipitated with AKT in two PC cells with CPA4 high expression. Conversely, CPA4 silencing inhibited EMT in PANC-1 cells. CPA4 overexpression or silencing promoted or inhibited cell proliferation and drug resistance in Capan-2 and PANC-1 cells via regulating Bcl2/Bax and cleaved-caspase3 signaling. However, LY294002 reversed CPA4 overexpression-stimulated cell proliferation and drug resistance in vitro in Bcl2/Bax and caspase3-dependent apoptosis. Conclusion:CPA4 overexpression contributes to aggressive clinical stage of PC patients and promotes EMT in vitro via activation of PI3K-AKT-mTOR signaling.

SUBMITTER: Shao Q 

PROVIDER: S-EPMC7457871 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

CPA4 Promotes EMT in Pancreatic Cancer via Stimulating PI3K-AKT-mTOR Signaling.

Shao Qingliang Q   Zhang Zhiqiang Z   Cao Rongxian R   Zang Hui H   Pei Wanting W   Sun Tian T  

OncoTargets and therapy 20200825


<h4>Background</h4>Carboxypeptidase A4 (CPA4), as a novel tumor biomarker, is prevalently observed in various cancers. However, the potential role of CPA4 in pancreatic cancer (PC), to our knowledge, has not been fully clarified.<h4>Materials and methods</h4>We systematically explored the detailed function of CPA4 in epithelial to mesenchymal transition (EMT) stimulated PC in human clinical samples and in vitro.<h4>Results</h4>CPA4 was overexpressed in clinical PC samples that was positively rel  ...[more]

Similar Datasets

| S-EPMC8370876 | biostudies-literature
| S-EPMC10726507 | biostudies-literature
| S-EPMC5295437 | biostudies-literature
| S-EPMC10242197 | biostudies-literature
| S-EPMC9399417 | biostudies-literature
| S-EPMC6127928 | biostudies-literature
| S-EPMC8461913 | biostudies-literature
| S-EPMC9832654 | biostudies-literature
| S-EPMC7590591 | biostudies-literature
| S-EPMC10552716 | biostudies-literature